They may let this run a little, but come Feb. 15th
they will bring it back under 9 again. The upgrade today helps as it gives us more exposure and helps validate the stock, but it is not significant enough news to propel the price much higher. MM's know they can manipulate .20-.40¢ out anytime they want. There will be continued mb chatter about these conferences, but nothing will come from them as they tend to be updates and refresher courses on where we've been, where we're at presently, and where we're hoping to go in the future. And, it's always good exposure for the company and management at breakout sessions. The road to success is often very long, lonely, and bumpy. JMO
dea will take its sweet time, 30 days are up on the 18th but they can take up to 45 days or early march before final..The waiver request by Eisai will probably be granted since all have been granted in the past...So final and effective can occur between the 18th of feb and the 4th of march..Then LAUNCH of Belviq...Between the 18th and 4th is where we could be surprised
You may be right, and you may be wrong. Last conference saw 30M shares (or was it EMA chatter) on Jan 9th or so. Same time as PRAC was meeting. We'll never know.
People were posting that some big house (Goldman) was buying up a 10M lot. Whatever, just don't fall in love with the Opex thesis - normally valid - but note that FEB options are tiny vs. the JAN ones.
Yes they are small compared to Jan.'s. I am not in love with the thesis, but more times than not it seems to be a reason to drag the price back below critical areas. The window is narrowing, but no one knows how fast. Lots of catalysts have been identified, yet timeframes are vague and unknown for all. So we all just sit and speculate about who, when, where, and how much?